Related articles
-
NewsmRNA flu vaccine offers immune protection against wide array of influenza virus strains
A new study has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today’s standard flu shot, offering stronger and potentially longer-lasting protection. The vaccine, developed by Moderna, is currently under review by the U.S. Food and Drug Administration.
-
NewsStudy reveals 45 new toxins produced by bacteria associated with foodborne infections
Researchers have discovered 45 new toxins produced by Salmonella bacteria, some of which are associated with foodborne infections. The study shows that these substances primarily act in the competition among microorganisms for space and resources.
-
News
A gut bacteria molecule may calm intestinal inflammation by turning down cellular energy
A new study suggests enterobactin, a molecule produced by gut bacteria, could offer a new pathway for treating inflammatory bowel disease.
More from News
-
NewsMetformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long Covid by 50%
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.
-
NewsHow exercise fights implant infections: Muscle hormone “musclin” unveiled as a key defender
A new study reveals how the exercise-induced myokine musclin reprograms macrophage metabolism to clear dead cells and treat periprosthetic joint infections.
-
NewsGut bacteria linked to osteoporosis risk in primary hyperparathyroidism
Researchers studying primary hyperparathyroidism, a common endocrine disorder characterized by excessive secretion of parathyroid hormone, have identified Bifidobacterium longum as a potential microbial driver of bone loss through immune-mediated mechanisms.
No comments yet